Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice

Cancer Gene Therapy

Volumn 8, Issue 8, 2001, Pages 573-579

  Yoon, Seung Kew ^a,b   Armentano, Donna ^c   Wands, Jack R ^a,d   Mohr, Leonhard ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b The Catholic University of Korea   (South Korea)

^c GENZYME CORPORATION   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adenoviral vectors; Gene delivery; Gene therapy; Hepatoma

Indexed keywords

AD2CMVBGAL; BETA GALACTOSIDASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOENZYME TECHNIQUES; INJECTIONS, INTRAVENOUS; LAC OPERON; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; RISK FACTORS; TRANSGENES;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 0034868473     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700345     Document Type: Article

References (43)

1. Rising incidence of hepatocellular carcinoma in the United States
2. The increasing incidence of hepatocellular carcinoma
3. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries
4. Primary hepatocellular carcinoma
5. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
6. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
7. Treatment of hepatocellular carcinoma
8. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus
9. Safety evaluation of Ad5CMV-p53 in vitro and in vivo
10. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression
11. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
12. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene
13. Rabbit cytochrome P450 4B1: A novel prodrug-activating gene for pharmacogene therapy of hepatocellular carcinoma
14. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene
15. Gene therapy for hepatocellular carcinoma: Long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo
16. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer
17. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2
18. Combined gene therapy with suicide gene and interleukin- 12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma
19. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin-12
20. A "distant" bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor
21. Drug sensitivity "suicide" genes for selective cancer chemotherapy
22. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors
23. Cationic liposome mediated gene delivery to the liver and to hepatocellular carcinomas in mice
24. Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas
25. A blood-tumor barrier limits gene transfer to experimental liver cancer: The effect of vasoactive compounds
26. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma
27. Assessment of recombinant adenoviral vectors for hepatic gene therapy
28. Therapeutic serum concentrations of human alpha- 1 -antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes
29. Human gene therapy
30. Adenoviruses as cloning vectors
31. The basic science of gene therapy
32. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression
33. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy
34. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig
35. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver
36. The hepatic microvascular system
37. An immunohistochemical study of the blood vessels within primary hepatocellular tumours
38. Barriers to drug delivery in solid tumors
39. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery
40. Production of embryonal serum globulin by hepatomas: Review of experimental and clinical data
41. Hepatocellular carcinoma
42. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma
43. Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate